Skip to content

Clinical application study of oxytocin in overweight/Obesity type 2 diabetes mellitus

Clinical application study of oxytocin in overweight/Obesity type 2 diabetes mellitus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014860
Enrollment
Unknown
Registered
2018-02-09
Start date
2018-08-01
Completion date
Unknown
Last updated
2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

Oxytocin groups:Oxytocin

Sponsors

Department of Endocrinology, Affiliated Hospital of Jiangsu University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. The criteria of diagnosis of type 2 diabetes recommended by WHO in 1999 were adopted; 2. fasting blood glucose levels 7.0-13.0mmol/L, or 2h Postprandial blood glucose 11.1-15mmol/L with glycosylated hemoglobin 7.0%-11.0%; 3. BMI>24kg/m2; 4. Did not use any hypoglycemic agents; 5. Subjects who signed an informed consent form prior to the start of the study and were willing and able to follow the protocol.

Exclusion criteria

Exclusion criteria: T2DM subjects who were treated with oral hypoglycemic agents were excluded to avoid the possible confounding effects of anti-diabetic medications. T1DM, individuals with gestational diabetes, active hepatitis/liver cirrhosis, chronic renal failure on hemodialysis, congestive heart failure or other known major disease were precluded from the study

Design outcomes

Primary

MeasureTime frame
Oxytocin;HbA1c;

Secondary

MeasureTime frame
BMI;insulin releasing test;blood lipid profiles;blood glucose;leptin;insulin;

Countries

China

Contacts

Public ContactYUAN Guoyue

Department of Endocrinology, Affiliated Hospital of Jiangsu University

yuanguoyue8@126.com+86 13505289352

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026